Pharma Supply ApS: Financial statements 2025
CVR: 44297981
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Supply ApS (CVR 44297981) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,508,452 and a net result of DKK 2,880,428. Equity in the 2025 report amounted to DKK 5,209,118. The solvency ratio was 80.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 5,508,452
- Profit/Loss
- DKK 2,880,428
- Equity
- DKK 5,209,118
- Total Assets
- DKK 6,493,757
- Employees
- 2
Official annual report
How creditworthy is Pharma Supply ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Supply ApS has published its interim report for the period September 8, 2023 – December 31, 2024.
As of January 27, 2025, LAMMP HOLDING ApS is registered as an owner of Pharma Supply ApS with an ownership share of 15%.
As of January 27, 2025, Tjikan Holding ApS is registered as an owner of Pharma Supply ApS with an ownership share of 50%.
About Pharma Supply ApS
Pharma Supply ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Michael Knipchildt Skriver. The company is owned by LAMMP HOLDING ApS, Tjikan Holding ApS and Fie & Peter Holm Holding ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 5,508,452 and a net result of DKK 2,880,428. Equity in the 2025 report amounted to DKK 5,209,118.